Basement membranes (BMs) are cell-associated extracellular matrices that support tissue integrity, signaling, and barrier properties. Type IV collagen is critical for BM function, yet how it is directed into BMs in vivo is unclear. Through live-cell imaging of endogenous localization, conditional knockdown, and misexpression experiments, we uncovered distinct mechanisms of integrin-mediated collagen recruitment to Caenorhabditis elegans postembryonic gonadal and pharyngeal BMs. The putative laminin-binding αINA-1/βPAT-3 integrin was selectively activated in the gonad and recruited laminin, which directed moderate collagen incorporation. In contrast, the putative Arg-Gly-Asp (RGD)-binding αPAT-2/βPAT-3 integrin was activated in the pharynx and recruited high levels of collagen in an apparently laminin-independent manner. Through an RNAi screen, we further identified the small GTPase RAP-3 (Rap1) as a pharyngeal-specific PAT-2/PAT-3 activator that modulates collagen levels. Together, these studies demonstrate that tissues can use distinct mechanisms to direct collagen incorporation into BMs to precisely control collagen levels and construct diverse BMs.
Basement membrane (BM) is a thin, dense sheet of extracellular matrix that underlies epithelia and endothelia and surrounds most other tissues (Pozzi et al., 2017). BMs are comprised primarily of two independent self-assembling scaffolds of laminin and type IV collagen. The laminin and type IV collagen networks are thought to associate through several cross-bridging molecules, including nidogen, perlecan, and agrin (Yurchenco, 2011). BMs are highly diverse, and this diversity arises from alternative splicing, post-translational modifications, and varying amounts of core BM components as well as numerous regulatory proteins that associate with BMs such as matricellular proteins, proteases, and growth factors (Glentis et al., 2014; Isabella and Horne-Badovinac, 2015). The diversity in BMs regulates key cell and tissue properties, including cell polarity, cell differentiation, cell survival, tissue shaping, filtration, and resistance to mechanical stresses (Breitkreutz et al., 2013). How diverse BMs are constructed on tissues is not well understood, particularly as many BM components are expressed and secreted from distant sources and selectively acquired from the extracellular fluid (Glentis et al., 2014; Clay and Sherwood, 2015).
Type IV collagen is highly conserved among animals, and its origination in unicellular ancestors was thought to have been a requirement for the formation of BMs and appearance of complex tissues in animals (Grau-Bové et al., 2017; Fidler et al., 2018). Type IV collagen is a heterotrimer made up of two α1-like and one α2-like chains that wind around each other into a long and rigid 400-nm triple helix. Vertebrates harbor three α1-like and three α2-like chains and construct three distinct heterotrimers (Khoshnoodi et al., 2008). The stiff triple-helical structure together with covalent cross-linking between type IV collagen molecules gives BMs mechanical resistance to tensile forces (Fidler et al., 2018). In addition to providing structural integrity, type IV collagen networks function as molecular scaffolds that bind other BM components, growth factors, and extracellular enzymes (Wang et al., 2008; Parkin et al., 2011; Brown et al., 2017). Furthermore, distinct levels, unique modes of deposition, and targeted remodeling of collagen within BMs helps shape organs (Gupta et al., 1997; Pöschl et al., 2004; Harunaga et al., 2014; Isabella and Horne-Badovinac, 2016; Crest et al., 2017). Highlighting its importance to human health, mutations in type IV collagen are associated with at least 10 distinct genetic disorders that disrupt brain, kidney, muscle, and vascular tissues (Fidler et al., 2018). In mice, Drosophila melanogaster, and Caenorhabditis elegans, type IV collagen is often secreted by cells into the extracellular space and then incorporated into epithelial BMs at distant sites (Graham et al., 1997; Kedinger et al., 1998; Pastor-Pareja and Xu, 2011). Work in Drosophila and mouse embryos have indicated that type IV collagen recruitment to BMs requires the presence of laminin (Pöschl et al., 2004; Urbano et al., 2009; Matsubayashi et al., 2017). Cell culture work has suggested that laminin deposition onto cell surfaces is mediated through interactions with integrin and dystroglycan receptors, and with sulfated glycolipids (Li et al., 2005, 2017; Yurchenco, 2011). The cell surface mechanisms that mediate laminin and collagen deposition in vivo, however, remain elusive. Further, while most studies have examined initial BM formation in the embryo, little is known about BM construction on growing tissues, where most BMs are found.
Many factors have limited the study of how BMs are constructed and the mechanisms by which type IV collagen is deposited into them. Laminin and type IV collagen are essential for embryonic animal development, hindering postembryonic studies. Further, in vertebrates there are three distinct type IV collagens, 16 laminins, and at least 24 integrin αβ heterodimer receptors, making interpretation of genetic analysis daunting (Clay and Sherwood, 2015). In addition, BM components and receptors have not yet been tagged in vertebrates with genetically encoded fluorescent proteins to dynamically examine their localization (Kelley et al., 2014). C. elegans is a powerful model system to address many of these experimental limitations. Type IV collagen and laminin, as well as many BM-interacting receptors, have been functionally tagged with fluorescent proteins (Hagedorn et al., 2009; Ihara et al., 2011; McClatchey et al., 2016). Further, core BM matrix components and receptors are conserved in the worm but have not undergone the dramatic gene family expansion found in vertebrates. For example, C. elegans has only a single type IV collagen, two laminins, and two integrin heterodimers. Finally, RNAi can be used to conditionally knock down BM components postembryonically to avoid early lethality (Clay and Sherwood, 2015).
In this work, we examined the mechanism of type IV collagen addition into the growing BMs covering two organs during C. elegans larval development: the pharynx, a rigid pumping feeding organ, and the gonad, a flexible cylindrical organ that houses the germline. Using RNAi-mediated knockdown and an mCherry-tagged type IV collagen reporter, we found that collagen addition to BM was required to maintain both organs’ structure, and that the pharyngeal BM contained significantly higher collagen levels. Strikingly, while laminin was necessary for type IV collagen addition into the gonadal BM, collagen addition appeared to be independent of laminin in the pharyngeal BM. Through RNAi screening and examination of endogenously tagged BM-binding receptors, we discovered that the putative laminin-binding integrin heterodimer αINA-1/βPAT-3 mediated laminin and collagen addition to the gonadal BM, while the putative Arg-Gly-Asp tripeptide (RGD)-binding integrin αPAT-2/βPAT-3 (Ruoslahti, 1996) promoted collagen addition to the pharyngeal BM, which appeared to be independent of laminin. However, both integrin heterodimers were expressed in the gonad and the pharynx, suggesting that their selective activation was controlled by tissue-specific effectors. Consistent with this hypothesis, domain-swapping experiments demonstrated that the intracellular domain of the α-integrin PAT-2 drove BM recruiting activity of the INA-1 extracellular domain in the pharynx, where INA-1 is normally not active. Further, using an RNAi screen we identified RAP-3, an orthologue of the mammalian integrin-activating small GTPase Rap1, as a pharyngeal-specific activator of PAT-2/PAT-3. Together, these results identify integrin receptors as key in vivo mediators of collagen incorporation into BM during tissue growth and show that BM diversity and precise modulation of BM collagen levels can be driven in part by the tissue-specific activation of distinct integrins.
The pharynx and gonad are BM-encased growing organs supported by type IV collagen
In C. elegans, collagen IV is a heterotrimer formed from two α1-like chains and one α2-like chain, encoded by the emb-9 and let-2 genes, respectively (Kramer, 2005). Collagen is predominantly synthesized in body wall muscles, secreted into the extracellular space, and then recruited to the BMs of other tissues (Graham et al., 1997; Morrissey et al., 2016). To understand how type IV collagen is targeted to the BMs of growing organs, we examined the BMs of the pharynx and the gonad (Fig. 1 A). The C. elegans pharynx is a rigid, contractile feeding apparatus largely composed of radially arranged muscle and marginal cells that form an epithelium (Mango, 2007). The gonad is a flexible cylindrical reproductive organ that is enwrapped predominantly by thin gonadal sheath cells (Sherwood and Plastino, 2018). The pharyngeal epithelium and gonadal sheath cells are both surrounded by BMs that support each organ (Huang et al., 2003). Using a functional type IV collagen reporter (EMB-9::mCherry [Ihara et al., 2011], referred to as collagen::mCh), we examined surface area projections of the gonadal and pharyngeal BMs and found that the pharyngeal BM grew approximately threefold in surface area during larval development (L1 through young adult), while the gonadal surface area increased >90-fold (Fig. 1 B). To determine if type IV collagen addition was required to maintain BM and tissue integrity during pharynx and gonad growth, we depleted EMB-9 protein (α1-like chain) by RNAi beginning at the L1 larval stage and analyzed both organs at adulthood (48 h and 72 h, Fig. 1 A). We found that reduction of EMB-9 frequently resulted in deformation of the anterior pharyngeal bulb (n = 15/20 72-h adult animals, Fig. 1 C), and severe distortion and rupturing of gonadal tissue (n = 20/20 48-h young adult animals, Fig. 1 C). Similar results were observed upon RNAi knockdown of let-2 (the α2-like chain of collagen IV, n = 17/20 animals with anterior pharyngeal bulb deformation and n = 20/20 animals with gonadal rupturing). Linescan analysis of mean fluorescence intensity revealed an ∼70% reduction in collagen::mCh levels in the pharyngeal BM. Further, gaps in collagen signal appeared at regions of pharyngeal bulb deformation (Fig. 1 C). Collagen was reduced by ∼60% in the gonad at the early L3 stage, before BM rupturing and the gonadal tissue became disorganized (Fig. 1 C). Taken together, these results indicate that addition of type IV collagen to the BM is necessary to maintain tissue integrity during pharyngeal and gonadal growth.
The pharyngeal BM is collagen rich, but laminin poor, compared with the gonadal BM
BMs of different tissues often vary in levels and composition of matrix components (Halfter et al., 2015; Randles et al., 2017). To determine if type IV collagen levels differ between the gonadal and pharyngeal BMs, we quantified collagen::mCh fluorescence intensity in both organs and found that collagen was present at twofold higher levels in the pharyngeal BM versus the gonadal BM in 72-h adults (Fig. 2). As embryonic studies have suggested that collagen is recruited to BMs through association with laminin networks (Huang et al., 2003; Pöschl et al., 2004; Urbano et al., 2009; Matsubayashi et al., 2017), we next analyzed BM laminin levels in the two tissues. Laminins are heterotrimers comprised of an α, β, and γ chain. C. elegans encodes two α subunits (lam-3 and epi-1), one β subunit (lam-1), and one γ subunit (lam-2) that form two distinct laminin heterotrimers (Kramer, 2005). To assess laminin levels in the BM, we used CRISPR/Cas9 to encode mNeonGreen at the lam-2 genomic locus, generating worms expressing the LAM-2::mNG fusion protein (referred to as laminin::mNG). We found that there were twofold lower levels of laminin in the pharyngeal BM compared with the gonadal BM (Fig. 2). Thus, there are higher levels of type IV collagen and lower levels of laminin in the pharyngeal BM compared with the gonadal BM.
Laminin is required for collagen recruitment to the gonadal but not pharyngeal BM
The differences in collagen and laminin levels in the adult pharyngeal and gonadal BMs suggested that the interaction between type IV collagen and laminin may differ in the BMs of these tissues. The early deposition of laminin is essential for polarizing the nascent pharyngeal epithelium during embryonic development, and for the addition of type IV collagen and perlecan during late embryogenesis (Rasmussen et al., 2012). We next asked whether laminin was required to recruit collagen to the postembryonic BMs of the pharynx and the gonad during larval development. We used RNAi to deplete LAM-2 (the sole laminin γ subunit) beginning in the L1 larval stage and analyzed BM collagen levels during subsequent larval development and adulthood. By the early L3 larval stage (24-h RNAi treatment), there was an ∼50% reduction in gonadal BM laminin levels (Fig. S1 A), correlating with a similar reduction in type IV collagen levels (Fig. 3 A). Breaks in the BM were observed shortly after this time (∼26-h RNAi treatment, n = 12/20 animals), followed by BM rupturing (mid L4, Fig. 3 A, n = 20/20 worms), and ultimately gonadal tissue disintegration (72-h adult, Fig. 3 A, n = 20/20 animals examined). In contrast, the pharyngeal BM collagen levels increased (similar to control animals) despite a strong knockdown of laminin (∼70% reduction in laminin levels by 96-h adult, Figs. 3 B and S1 B), and there were no defects in pharyngeal structure (n = 14/14 animals). These observations suggest that type IV collagen recruitment to the growing BM might be distinct in each tissue: laminin dependent in the gonad but possibly laminin independent in the pharynx.
INA-1/PAT-3 integrin mediates collagen recruitment to the gonadal BM in a laminin-dependent manner
Work in cell culture has suggested that interactions with laminin-binding integrin and dystroglycan receptors as well as cell surface sulfated glycolipids might seed laminin polymerization to initiate BM assembly, leading to subsequent collagen recruitment (Yurchenco and Patton, 2009; Li et al., 2017). Because of possible redundancy between these mechanisms and within the large integrin gene family in vertebrates, however, there has not yet been clear genetic evidence for any of these mechanisms in regulating laminin and collagen recruitment to BMs in vivo (Yurchenco, 2015). As C. elegans does not synthesize sulfated glycolipids (Bai et al., 2018), we hypothesized that tissue-specific roles for integrin and dystroglycan might explain the different modes of collagen recruitment to the pharyngeal and gonadal BMs.
To investigate the cell surface interactions that recruit type IV collagen to developing tissues, we initially focused on the gonadal BM. We first examined the dystroglycan receptor. C. elegans harbors a single vertebrate dystroglycan orthologue, dgn-1 (Johnson et al., 2006). Endogenously tagged DGN-1::mNG (Naegeli et al., 2017) was expressed in the gonad and localized to the gonad–BM interface (Fig. S2 A). Knockdown of dgn-1 by RNAi eliminated detectable DGN-1::mNG but did not affect either laminin or collagen levels in adult animals (Fig. S2 B). We next investigated the integrin receptor system. C. elegans assembles two integrin heterodimers, composed of the α subunits PAT-2 (most similar to RGD-binding integrins) or INA-1 (most similar to laminin-binding integrins) dimerized to the sole β subunit PAT-3 (Kramer, 2005). Endogenously tagged INA-1::mNG, PAT-2::2XmNG, and PAT-3::mNG were expressed in the gonad and localized to the cell–BM interface (Fig. 4 A). L1 RNAi-mediated knockdown of ina-1 and pat-3 each resulted in an ∼50% reduction in collagen::mCh levels in adult animals (Figs. 4 B and S3 A), suggesting that the INA-1/PAT-3 integrin heterodimer is required for type IV collagen recruitment to the gonadal BM. Importantly, RNAi against ina-1 and pat-3 did not appear to alter collagen secretion from the muscle cells (Fig. S3 B), suggesting a local collagen-recruiting function for INA-1/PAT-3 in the gonad. As gonadal BM collagen localization is dependent on laminin, we analyzed laminin::mNG levels upon ina-1 and pat-3 knockdown and found a similar ∼50% reduction (Fig. 4 B) in each condition. Surprisingly, depletion of the other integrin α subunit PAT-2 by RNAi yielded an increase in BM collagen and laminin levels (Figs. 4 B and S3 A). We speculated that this could be due to more INA-1/PAT-3 heterodimers forming upon reduction of PAT-2. Consistent with this, RNAi against pat-2 more than doubled INA-1::mNG levels at cell surfaces contacting the gonadal BM (Fig. S3 C).
To determine if any other matrix receptors contribute to collagen recruitment to the gonadal BM, we performed RNAi against worm orthologues of glypican (gpn-1 and lon-2), leukocyte common antigen-related receptor protein tyrosine phosphatase (ptp-3), teneurin (ten-1), and discoidin domain receptors (ddr-1 and ddr-2; Kramer, 2005). Knockdown of these receptors did not affect gonadal collagen levels (Fig. S3 D). Taken together, our findings suggest that the putative laminin-binding INA-1/PAT-3 integrin heterodimer is the predominant cell surface receptor that mediates collagen IV recruitment to the gonadal BM through a laminin-dependent mechanism.
The PAT-2/PAT-3 integrin heterodimer promotes collagen recruitment to the pharyngeal BM independent of laminin
We next sought to determine the cell surface receptors mediating collagen recruitment to the pharyngeal BM. DGN-1::mNG expression was not detectable in the pharynx (Fig. S4 A). In contrast, all three integrin subunits were present in the pharyngeal epithelium and localized to the pharynx–BM interface (Fig. 5 A). RNAi against ina-1 did not affect pharyngeal BM collagen or laminin levels (96 h RNAi treatment, Figs. 5 B and S4 B). However, RNAi targeting pat-2 and pat-3 each reduced pharyngeal BM collagen levels by >40% (Figs. 5 B and S4 B). Notably, RNAi against pat-2 or pat-3 did not affect pharyngeal BM laminin levels (Fig. 5 B). These results suggest that the PAT-2/PAT-3 integrin promotes pharyngeal BM collagen recruitment independent of laminin. To determine whether PAT-2 is sufficient to recruit collagen to the pharyngeal BM, we overexpressed PAT-2::mNG specifically in pharyngeal muscle cells by using the myo-2 promoter and mosaic extrachromosomal array expression (Fig. 5 C). Analysis of mosaic overexpression in adult animals revealed that pharyngeal BM collagen::mCh levels were increased by ∼30% in regions where PAT-2 was overexpressed (Fig. 5 C). Finally, RNAi-mediated reduction of other major matrix receptors did not affect collagen levels in the pharyngeal BM (Fig. S4 C). Together, these observations indicate that the putative RGD-binding PAT-2/PAT-3 integrin heterodimer is the predominant cell surface receptor that is required and sufficient to mediate type IV collagen recruitment to the pharyngeal BM independent of laminin. Further, these results suggest that the recruitment of laminin to the growing pharyngeal BM is not dependent on integrins (either INA-1/PAT-3 or PAT-2/PAT-3) but is mediated by an unknown mechanism.
The PAT-2 intracellular domain dictates BM recruiting activity of integrins in the pharynx
All integrin subunits were expressed in both the gonadal and pharyngeal tissues. Thus, we next sought to determine the mechanism controlling the tissue-specific activity of the two integrin heterodimers in matrix recruitment. Recent studies have suggested that the diverse intracellular C-terminal membrane-distal (CTMD) regions of vertebrate α-integrins may provide specificity for integrin inside-out activation, a form of integrin activation where intracellular regulators bind the cytoplasmic tails of integrin heterodimers and trigger conformational changes that allow high-affinity binding of the integrin extracellular domain with matrix ligands (Thinn et al., 2018). As the sole difference between INA-1/PAT-3 and PAT-2/PAT-3 integrin heterodimers is the α subunit, we speculated that their tissue-specific activity in collagen recruitment could be regulated by their distinct α-integrin intracellular domains mediating inside-out activation. Indeed, INA-1 and PAT-2 diverge significantly in their CTMD regions (Fig. 6 A).
Building off of these studies, and our findings that INA-1/PAT-3 integrin is expressed in the pharynx but does not recruit laminin to the pharyngeal BM, we hypothesized that the pharynx-active intracellular domain of PAT-2 fused to the laminin-binding extracellular domain of INA-1 might be able to recruit laminin in this tissue. We engineered animals that express this chimeric α-integrin subunit in the pharynx (myo-2p::INA-1[EX]::PAT-2[CTMD]::mNG; Fig. 6 B). Mosaic overexpression of this chimeric integrin resulted in an ∼50% increase in laminin levels in regions of the BM contacting chimera-expressing pharyngeal cells (Fig. 6 C). Notably, despite increased laminin levels, BM collagen levels were unaffected (Fig. 6 D), offering further support for the laminin-independent recruitment of collagen to the BM. In addition, we hypothesized that overexpression of the reciprocal chimeric α-integrin (PAT-2[EX]::INA-1[CTMD]) or full-length INA-1 in the pharynx might outcompete PAT-2 for PAT-3 binding and thus would disrupt collagen recruitment to the pharyngeal BM. However, we could not view transgenic animals expressing these constructs in the pharynx, as they died during embryonic development or shortly after hatching. Together, our findings suggest that the cytoplasmic domain of PAT-2 facilitates the PAT-2/PAT-3–mediated recruitment of collagen to the pharyngeal BM and when attached to the extracellular domain of INA-1 triggers laminin recruitment instead.
RAP-3 is a pharyngeal-specific activator of PAT-2/PAT-3 integrin
Our results suggested that there might be tissue-specific factors that activate PAT-2/PAT-3 in the pharynx via the PAT-2 intracellular domain to mediate BM matrix recruitment. Proteomic, localization, and genetic screening approaches have identified numerous proteins that localize with integrins or regulate integrin activity (Horton et al., 2016). To identify potential tissue-specific regulators of PAT-2/PAT-3 integrin-mediated collagen IV recruitment to BM, we performed a targeted RNAi screen (Table S1) of C. elegans orthologues of 32 known integrin-associated or regulatory proteins (Bouvard et al., 2013; Horton et al., 2015; Lilja et al., 2017). We searched for proteins whose loss reduced type IV collagen levels in the pharyngeal BM but did not affect gonadal BM collagen levels. RNAi against one gene, rap-3, led to an ∼40% reduction of pharyngeal type IV collagen levels without affecting gonadal BM collagen, suggesting it could be a specific activator of PAT-2/PAT-3 in the pharynx (Table S1 and Fig. 7, A and B).
The rap-3 gene encodes a Rap-like protein most similar to the mammalian Rap1 isoforms Rap1A and Rap1B (Reiner and Lundquist, 2018). Rap1 is a member of the Ras family of small GTPases, and Rap1 has been implicated as an activator of integrins in numerous contexts, especially in blood and endothelial cells (Boettner and Van Aelst, 2009; Carmona et al., 2009; Lagarrigue et al., 2016). To determine if the RAP-3 protein might be a tissue-specific regulator of PAT-2/PAT-3 integrin activity, we first generated RAP-3::mNG–expressing animals using CRISPR/Cas9 genome editing. Consistent with a pharynx-specific function, we found that RAP-3::mNG was expressed in the pharynx of larval and adult animals but was not detectable in gonadal tissue (Figs. 7 C and S5 A).
We hypothesized that if RAP-3 specifically activates PAT-2/PAT-3 to recruit type IV collagen, then it would not be involved in laminin recruitment. Supporting this notion, we found that pharyngeal BM laminin levels were unaffected by RNAi targeting rap-3 (Figs. 7 D and S5 B). Further, pharyngeal-specific overexpression of a constitutively active form of RAP-3 (RAP-3G12V; Jeon et al., 2007) resulted in an ∼50% increase in collagen levels in regions of the pharyngeal BM in contact with RAP-3G12V-overexpressing cells (Fig. 7 E). To test whether RAP-3 and PAT-2 might function in the same genetic pathway to mediate type IV collagen recruitment, we first generated a rap-3 null mutation, rap-3(qy67), using CRISPR/Cas9 genome editing. However, we were unable to view homozygous rap-3(qy67) mutant larval animals due to embryonic lethality. To circumvent embryonic lethality, we knocked down pat-2 and rap-3 simultaneously by RNAi beginning at the L1 larval stage. The combined RNAi against rap-3 and pat-2 did not worsen the reduction in pharyngeal BM collagen levels caused by individual pat-2 or rap-3 knockdown, consistent with these genes functioning within the same pathway (Fig. S5 C). We also found that knockdown of rap-3 did not alter PAT-2 or PAT-3 localization or levels (Fig. S5 D), suggesting that it does not activate PAT-2/PAT-3 by regulating integrin trafficking. Together, our observations support the idea that RAP-3 is a pharyngeal-specific activator of the PAT-2/PAT-3 integrin, triggering its ability to recruit type IV collagen to the pharyngeal BM.
Finally, we wanted to test if ectopic expression of RAP-3 in the gonad was sufficient to activate PAT-2/PAT-3 in this tissue to facilitate collagen recruitment. We used the inx-8 promoter and extrachromosomal mosaic expression to drive RAP-3::mNG expression in the gonadal sheath cells (Starich et al., 2014) that contact BM (Fig. 8 A). Strikingly, we found that ectopic mosaic RAP-3 expression in the gonadal sheath cells increased collagen levels by ∼80% in regions of the BM contacting RAP-3–expressing cells (Fig. 8 A). We predicted that if RAP-3 was triggering collagen recruitment by activating PAT-2/PAT-3 in the gonad, then laminin levels would not be altered. Consistent with this, we found that gonadal expression of RAP-3 did not affect BM laminin levels (Fig. 8 B). Together, these observations strongly suggest that RAP-3 is a tissue-specific activator of PAT-2/PAT-3 integrin, which directs the laminin-independent addition of type IV collagen into the BM.
Type IV collagen is critical for BM function, and numerous human diseases are associated with its misregulated accumulation or loss (Fidler et al., 2018). Previous work has suggested that a meshwork of laminin forms a cell-bound template that recruits the type IV collagen network through cross-bridging components (Glentis et al., 2014; Pozzi et al., 2017). How laminin is targeted to cell surfaces and whether there are other mechanisms to direct collagen to BMs in vivo has remained unclear. Through live-cell imaging of endogenous localization, conditional knockdown, misexpression, and RNAi screening, we have discovered distinct mechanisms for type IV collagen recruitment to the growing BMs of the C. elegans pharyngeal and gonadal tissues. We found that the two C. elegans integrin α subunits, INA-1 (laminin-binding) and PAT-2 (RGD-binding), are expressed with the sole β subunit PAT-3 in both organs. Our results suggest each tissue promotes selective activation of a specific integrin heterodimer to recruit collagen from the extracellular fluid: αINA-1/βPAT-3 activation in the gonad recruits laminin, which directs moderate amounts of collagen to the BM, while αPAT-2/βPAT-3 activation in the pharynx recruits high levels of collagen in an apparently laminin-independent manner. Supporting this model, we identified a putative pharyngeal-specific PAT-2/PAT-3 activator, the small GTPase RAP-3, which is an orthologue of mammalian Rap1 that mediates inside-out activation of mammalian integrins (Boettner and Van Aelst, 2009). Collectively, these data reveal how tissues dictate collagen incorporation into BM through selective integrin activation and provide insight into how cells can use distinct mechanisms to target collagen to BMs, thereby precisely controlling collagen levels and constructing diverse BMs (Fig. 8 C).
Due to the challenge of imaging of BMs in situ, the lethal phenotypes of null mutations of many BM components, and the expanded gene families of BM receptors and matrix components in vertebrates, it has been difficult to establish the mechanisms that mediate type IV collagen recruitment to BMs in vivo (Yurchenco and Patton, 2009; Li et al., 2017). Studies in vitro have suggested that several mechanisms might recruit laminin to cell surfaces, which in turn mediates type IV collagen incorporation. For example, work on embryoid bodies—groups of pluripotent embryonic stem cells—has indicated that integrin β1 and dystroglycan matrix receptors function redundantly to promote the anchorage of laminin to the surfaces of cells (Li et al., 2017). Findings in cultured rat Schwann cells have further suggested that sulfated glycolipids mediate laminin deposition (Li et al., 2005). Here, we exploited the small BM receptor and matrix families of C. elegans (Clay and Sherwood, 2015), as well as their conditional knockdown by RNAi, to investigate how the sole C. elegans type IV collagen molecule is recruited to the BMs of growing gonadal and pharyngeal organs during larval development. We demonstrate that the two C. elegans integrin heterodimers play key roles in BM recruitment: αINA-1/βPAT-3 promotes laminin-dependent type IV collagen recruitment to the gonadal BM, while αPAT-2/βPAT-3 directs collagen IV to the pharyngeal BM in a manner that appears to be independent of laminin. RNAi against these integrins did not reduce type IV collagen incorporation into the BMs as severely as knockdown of type IV collagen itself, suggesting that another cell surface system may function with integrin. However, C. elegans does not synthesize sulfated glycolipids (Bai et al., 2018), and knockdown of neither dystroglycan nor the matrix receptors glypican, discoidin domain receptors, leukocyte common antigen-related receptor protein tyrosine phosphatase, or teneurin reduced type IV collagen recruitment. Thus, integrins are likely the chief mediators of type IV collagen recruitment to the gonadal and pharyngeal BMs.
Laminin is required for the recruitment of type IV collagen to the BM of Drosophila and mouse embryos (Pöschl et al., 2004; Urbano et al., 2009; Matsubayashi et al., 2017). In addition, in embryoid bodies, the inhibition of laminin polymerization prevents the assembly of collagen IV on cell surfaces (Li et al., 2002). Further, in cultured Schwann cells, exogenously added collagen assembles into the BM-like matrix only in the presence of laminin (Tsiper and Yurchenco, 2002). Similarly, we found that collagen IV targeting to the gonadal BM was dependent on laminin. Comparatively little is known about laminin-independent collagen recruitment. BM collagen addition independent of laminin has recently been observed during wound repair in the Drosophila larval epidermal BM (Ramos-Lewis et al., 2018), but the receptors facilitating this mode of collagen targeting have not been identified. In our study, we found that reduction of laminin did not alter type IV collagen addition to the pharyngeal BM. We discovered that the PAT-2/PAT-3 integrin is required to recruit type collagen IV to the pharyngeal BM but not laminin. Further, we found that overexpression of a chimeric α-integrin subunit in the pharynx resulted in an increase in BM laminin levels, but collagen levels were unchanged. Taken together, these observations suggest a laminin-independent mode of PAT-2/PAT-3–mediated collagen recruitment to the larval pharyngeal BM. Importantly, we cannot definitively rule out a role for laminin, as we currently lack experimental means to eliminate laminin from postembryonic BMs. Genetic loss of laminin in embryos disrupts the later addition of type IV collagen during embryogenesis, although it is unclear if this is a result of a role for laminin in type IV collagen recruitment or because of an earlier role for laminin in polarizing the pharyngeal epithelium (Rasmussen et al., 2012). One possibility during BM expansion in the larval pharynx is that a small amount of preexisting laminin matrix is sufficient to facilitate PAT-2/PAT-3–mediated type IV collagen assembly. In support of this possibility, small amounts of laminin facilitate collagen assembly in cultured rat Schwann cells and cultured mouse myoblasts (McKee et al., 2009, 2017).
While BMs arose at the time of animal multicellularity, laminin- and type IV collagen–related genes and integrin receptors are present in unicellular protists that are sister groups to metazoans (King et al., 2008; Babonis and Martindale, 2017; Fidler et al., 2017; Grau-Bové et al., 2017). Thus, laminin- and type IV collagen–like proteins had roles independent of BMs and potentially independently of each other in unicellular ancestors of animals. How type IV collagen recruitment became dependent on laminin in the construction of BMs is unclear (Fidler et al., 2017). Further, it is possible that the apparently laminin-independent recruitment of collagen IV to the pharyngeal BM reflects an ancient collagen-specific targeting to cell surfaces that is used for tissue-specific BM construction. Alternatively, distinct modes of BM recruitment could be a mechanism that arose independently in animals to build unique BMs. Understanding the functions and interactions of laminin- and type IV collagen–like molecules in unicellular protists and basal metazoans will likely provide important insights into the origins of BMs and their diverse construction.
Sequence analysis suggests that PAT-2/PAT-3 is an RGD-binding integrin (Brown, 2000). As multiple RGD sequences are present in both α1 and α2 chains of C. elegans collagen IV, it is possible that PAT-2/PAT-3 directly binds collagen, thus precluding the need for a laminin template. Supporting this notion, we found that mosaic overexpression of PAT-2/PAT-3 in the pharyngeal tissue caused an increase in BM collagen levels only in regions of the BM contacting overexpressed PAT-2/PAT-3. Countering this idea, it has been suggested that the RGD sequences in collagen may not be sterically accessible to integrins (Khoshnoodi et al., 2008). Hence, an alternative possibility is that PAT-2/PAT-3 binds either to a cell surface or BM molecule that directly interacts with collagen. In Drosophila, the RGD-binding PS2 integrin (orthologous to PAT-2/PAT-3) binds to the extracellular matrix protein tiggrin, but it is unclear if tiggrin binds to type IV collagen or other matrix proteins (Fogerty et al., 1994; Bunch et al., 1998). The C. elegans genome does not encode tiggrin. However, one potential analogous ligand for PAT-2/PAT-3 integrin is UNC-52/perlecan, as it possesses RGD sequences and is localized to muscle attachment sites where PAT-2/PAT-3 is enriched (Gieseler et al., 2017).
Both the integrin α subunits INA-1 and PAT-2 and the β subunit PAT-3 are expressed in the gonad and the pharynx. Thus, tissue-specific integrin expression cannot account for the tissue-specific activity of gonadal INA-1/PAT-3 and pharyngeal PAT-2/PAT-3 in collagen recruitment. We considered the possibility that tissue-specific synthesis of laminin or type IV collagen might selectively activate gonadal INA-1/PAT-3 or pharyngeal PAT-2/PAT-3 heterodimers, respectively, as they are trafficked to cell surfaces (analogous to outside-in activation of integrin). However, this is unlikely, as laminin is produced by both tissues (Huang et al., 2003) and collagen is not synthesized in the pharyngeal epithelium (Graham et al., 1997). Since the sole difference between the αINA-1/βPAT-3 and the αPAT-2/βPAT-3 integrins is the α subunit, we propose instead that tissue-specific factors activate αINA-1 or αPAT-2 to promote their tissue-specific matrix-recruiting activity. One possible mode of activation is through the diverse cytoplasmic tail region of the α subunits. Studies in mammalian cell lines have shown that the cytoplasmic tails of α-integrin subunits are required for the inside-out activation of integrin receptors and may bestow specificity to integrin activation (Liu et al., 2015; Thinn et al., 2018). Supporting this idea, we found that expressing the PAT-2 α-integrin cytoplasmic tail fused to the INA-1 extracellular domain in the pharynx activated its ability to recruit laminin, even though INA-1 does not normally function in pharyngeal BM laminin recruitment during larval development. One puzzling question is the functional significance of the α subunit expressed in each tissue and localized to the cell–BM interface but not involved in BM recruitment. In the gonad, our evidence suggests that the α subunit PAT-2 acts in part to sequester the β subunit PAT-3, thus limiting the amount of active INA-1/PAT-3 heterodimer and thereby limiting laminin addition to the BM. It is also possible that α subunits not involved with BM recruitment may help localize proteases involved in matrix remodeling (Desgrosellier and Cheresh, 2010) or might be associated with intracellular effectors that allow it to be activated and signal in response to changing matrix and physiological conditions (Wolfenson et al., 2013).
In lymphocytes, coexpressed integrins αLβ2 and αMβ2, which share a common β subunit, are differentially activated through their divergent α cytoplasmic tails, triggering distinct adhesion responses to chemokine stimulation (Weber et al., 1999). Notably, the mammalian small GTPase Rap1 facilitates the activation of the αLβ2-integrin through the lymphoid-enriched Rap1 effector molecule RapL, which binds to the αL subunit (Katagiri et al., 2004; Zhang and Wang, 2012). In our study, through a targeted RNAi screen, we identified RAP-3, a C. elegans orthologue of mammalian Rap1, as a pharyngeal-expressed activator of the PAT-2/PAT-3 integrin’s collagen IV recruiting function. C. elegans encodes two Rap1 orthologues, rap-1 and rap-3 (Reiner and Lundquist, 2018), with rap-3 appearing to be more divergent (Rasmussen et al., 2018). We provide strong evidence that RAP-3 is a specific activator of PAT-2/PAT-3 integrin. First, similar to loss of PAT-2/PAT-3, loss of RAP-3 resulted in reduction of pharyngeal BM collagen but not laminin levels. Second, overexpression of a constitutively active mutant of RAP-3 in the pharyngeal epithelium increased collagen levels in regions of the pharyngeal BM contacting overexpressing cells, phenocopying our observations with pharyngeal PAT-2 overexpression. Third, our genetic analysis suggested that RAP-3 and PAT-2 act in the same pathway to promote collagen recruitment. Finally, ectopic expression of RAP-3 in the gonad increased type IV collagen levels in the gonadal BM, but not laminin levels, indicative of ectopic PAT-2/PAT-3 activation. The effectors of RAP-3 that promote PAT-2/PAT-3 activity in collagen recruitment to the BM are not known, but our data suggest they are likely expressed in both gonadal and pharyngeal tissues, as RAP-3 can activate PAT-2/PAT-3 in either tissue. Collectively, these observations support a model where the tissue-specific expression of RAP-3 in the pharynx promotes activation of PAT-2/PAT-3 to facilitate laminin-independent collagen recruitment to the BM and suggest that distinct tissue-specific factors might mediate INA-1/PAT-3 activation in the gonad to promote laminin-dependent BM collagen recruitment (Fig. 8 C).
The triple-helical nature of collagen combined with its intermolecular covalent cross-links provides BMs their tensile strength, and genetic elimination of type IV collagen results in embryonic lethality in mice and C. elegans when tissues first experience mechanical loads (Gupta et al., 1997; Pöschl et al., 2004). Type IV collagen also tethers numerous matrix proteins and growth factors (Fidler et al., 2018). As a result of its complex and essential roles, precise levels of BM collagen are required for many cell and tissue functions. For example, the bone morphogenetic protein/TGFβ ligand Dpp binds type IV collagen in Drosophila BMs, and collagen levels influence Dpp-mediated signaling during dorsal ventral patterning in the embryo, germ stem cell production in the ovary, renal tubule morphogenesis, and wing disc growth (Wang et al., 2008; Bunt et al., 2010; Ma et al., 2017). Further, specific levels and gradients of type IV collagen mediate tissue constriction and shaping in the Drosophila egg chamber and wing disc and the C. elegans gonad (Kubota et al., 2012; Morrissey and Sherwood, 2015; Crest et al., 2017). Distinct integrin receptors that mediate different modes of type IV collagen recruitment may provide tissues with robust mechanisms to control BM collagen levels. In particular, as PAT-2/PAT-3 activity is controlled by the small GTPase RAP-3, its activity, and thus levels of type IV collagen, can be finely tuned through GTPase-activating proteins and guanine nucleotide exchange factors. This could be a dynamic mechanism for tissues to increase, decrease, and even translate signaling pathways into collagen gradients (Crest et al., 2017; Jayadev and Sherwood, 2017). Therapeutically targeting specific activators of collagen-recruiting integrins may also be a promising means to modulate collagen levels during aging, in fibrotic diseases, and with type IV collagen genetic disorders where type IV collagen levels in BMs are altered, leading to tissue decline (Uspenskaia et al., 2004; Mao et al., 2015; Karsdal et al., 2016; Fidler et al., 2018).
Materials and methods
C. elegans strains
C. elegans strains used in this study are listed in Table S2. Worms were reared on nematode growth medium plates seeded with OP50 Escherichia coli at 16°C, 18°C, or 20°C according to standard procedures (Stiernagle, 2006).
To generate the following functional, genome-edited mNG knock-ins lam-2(qy20[lam-2::mNG + LoxP]), lam-2(qy41[lam-2::mKate2 + LoxP]), pat-3(qy36[pat-3::mNG + LoxP]), ina-1(qy23[ina-1::mNG + LoxP]), pat-2(qy26[pat-2::mNG + LoxP]), pat-2(qy49[pat-2::2xmNG + LoxP]), and rap-3(qy57[rap-3::mNG + LoxP]), we used CRISPR/Cas9 genome editing with a self-excising cassette (SEC) for drug (hygromycin) selection as described previously (Dickinson et al., 2015), with some modifications. Briefly, we generated new starter repair plasmids lacking the 3xFlag tag downstream of the SEC cassette sequence, and we attached an 18–amino acid (glycine-alanine-serine) flexible linker (flexlink) in-frame and directly upstream of mNG, mKate2, or two tandem mNG fluorophores. Approximately 700-bp to 1-kb left and right homology arms for each target were amplified from N2 genomic DNA (gDNA), mutated to introduce six silent point mutations adjacent to the Cas9 cut site, and inserted into the appropriate repair plasmid using Gibson assembly. We generated one or two single guide RNA (sgRNA) plasmids for each target by inserting the respective sgRNA sequences into the pDD122 plasmid. To direct cleavage near the C-terminus, the following sgRNA sequences were used: 5′-GTCATCAATTTGGAGCAAGA-3′ and 5′-ATTGATGACATTGAAGCATT-3′ for lam-2; 5′-TTGGCTTTTCCAGCGTATAC-3′ and 5′-TTTAAAAATCCAGTATACGC-3′ for pat-3; 5′-CGAGAAGAATGGGCTGATAC-3′ and 5′-ACGAGAAGAATGGGCTGATA-3′) for ina-1; 5′-CAGTACAATCAGGGACGTCA-3′ for pat-2; and 5′-ATCTAATCGTGTGCAAAACA-3′ for rap-3. For each tagging experiment, we injected a mixture of 50 ng/µl Cas9-sgRNA plasmids (25 ng/µl of each guide plasmid in cases where two sgRNAs were available), 100 ng/µl repair template plasmid, and red coinjection markers (2.5 ng/µl pCFJ90 [myo-2p::mCherry] and 5 ng/µl pCFJ104 [myo-3p::mCherry]) into the gonads of ∼30–40 young adult N2 animals. The injected animals were singled onto fresh OP50 plates and allowed to lay eggs for 3–4 d at 20°C in the absence of selection. Then, 500 µl of 2 mg/ml hygromycin solution was added to each plate, and the plates were returned to 20°C for 4–5 d. Candidate knock-in animals were roller (sqt-1(e1350), dominant Rol mutation) worms that survived the hygromycin treatment and lacked the red fluorescent extrachromosomal array markers. We were able to isolate approximately two to five independent lines for each construct. All initial insertion strains were homozygous viable and segregated 100% Rol progeny. To excise the SEC, we heat-shocked plates containing approximately six L3/L4 rollers each at 34°C in a water bath for 4 h, and then grew the animals at 20°C for 3–4 d. We singled adult wild-type animals (worms that lost both copies of the SEC) and verified successful genome editing by visualizing mNG/mKate2 fluorescence, PCR genotyping, and sequencing of the fluorophore insertion site.
To generate rap-3(qy67[mNG + SEC]), we used CRISPR/Cas9 genome editing with the SEC as described above to delete the endogenous rap-3 coding sequence and replace it with mNG. We directed cleavage near the N- and C-terminus of rap-3 using the following sgRNAs: 5′-TTTTGGGAAATGGAGGAGTT-3′ and 5′-ATCTAATCGTGTGCAAAACA-3′. We modified the starter repair template plasmid described above to include 1-kb left and right homology arms for rap-3.
myo-2p::pat-2::mNG::unc-54 3′ UTR
myo-2p::pat-2::mNG::unc-54 3′utr was built by Gibson assembling the following fragments in order: an ∼1-kb myo-2p fragment from the pCFJ90 vector, full-length pat-2 amplified from N2 gDNA, and flexlink::mNG::unc-54 3′utr.
myo-2p::ina-1[EX]::pat-2[CTMD]::mNG::unc-54 3′ UTR
To generate myo-2p::ina-1[EX]::pat-2[CTMD]::mNG::unc-54 3′utr, we first amplified full-length ina-1 and pat-2 from N2 gDNA and cloned these fragments into separate TOPO vectors. Then we used Gibson assembly to ligate the following fragments in order: an ∼1-kb myo-2p fragment from the pCFJ90 vector; ina-1 fragment containing only the extracellular, transmembrane, and intracellular membrane-proximal regions; pat-2 fragment containing only the CTMD; and flexlink::mNG::unc-54 3′utr.
myo-2p::rap-3G12V::mNG::unc-54 3′ UTR
To construct myo-2p::rap-3G12V::mNG::unc-54 3′utr, we first used Gibson assembly to connect the following fragments in order: an ∼1-kb myo-2p fragment from the pCFJ90 vector, full-length rap-3 amplified from N2 gDNA, and flexlink::mNG::unc-54 3′utr. We then introduced the G12V mutation in rap-3 by site-directed mutagenesis.
inx-8p::rap-3::mNG::unc-54 3′ UTR
To build inx-8p::rap-3::mNG::unc-54 3′utr, we replaced (by Gibson assembly) the myo-2p fragment in the myo-2p::rap-3::mNG::unc-54 3′utr construct created above with a 1.5-kb fragment upstream of inx-8 amplified from N2 gDNA.
All CRISPR/Cas9 genome-edited mNG/mKate2 knock-in strains were created by injecting the relevant constructs into the germline of young adult N2 worms as described earlier. All knock-in alleles were functional, and viability and growth rates of knock-in strains were similar to those of N2 animals. The rap-3(qy67) knockout strain was generated by injecting the relevant CRISPR/Cas9 constructs into the gonads of young adult NK364 animals. We were unable to isolate homozygous rap-3(qy67) animals, as the null mutation caused embryonic lethality.
Transgenic worms expressing myo-2p::pat-2::mNG::unc-54 3′utr or myo-2p::ina-1[EX]::pat-2[CTMD]::mNG::unc-54 3′utr were created by injecting these constructs (1.5 ng/µl) together with full-length pat-3 gDNA amplified from N2, EcoRI-digested salmon sperm DNA (50 ng/µl), and pBluescript II (50 ng/µl) into the gonads of young adult NK364 or NK2446 animals, respectively. Animals expressing myo-2p::rap-3G12V::mNG::unc-54 3′utr were created by coinjecting the construct (1.5 ng/µl) with EcoRI-digested salmon sperm DNA (50 ng/µl) and pBluescript II (50 ng/µl) into the gonads of young adult NK364 animals. Worms carrying inx-8p::rap-3::mNG::unc-54 3′utr were made by coinjecting the construct (50 ng/µl), EcoRI-digested salmon sperm DNA (50 ng/µl), pBluescript II (50 ng/µl), and a green coinjection marker (myo-2p::gfp, 2.5 ng/µl) into the gonads of NK364 or NK2446 animals. All of the above constructs were expressed mosaically in tissues as extrachromosomal arrays (Yochem and Herman, 2003). As the F1 progeny did not transmit these arrays stably to F2 progeny, we collected and imaged mosaic expression in F1s directly for the relevant experiments.
All RNAi constructs were obtained from the Vidal (Rual et al., 2004) and Ahringer (Kamath et al., 2003) libraries, except for the following clones: csk-1, kin-32, pix-1, rsu-1, unc-97, unc-112, and pat-3. To build these RNAi clones, we PCR-amplified fragments corresponding to the longest transcripts of these genes from N2 gDNA and inserted them into the L4440 (pPD129.36) vector (Timmons and Fire, 1998) by Gibson assembly. The forward and reverse primers used to amplify these fragments are as follows: csk-1, 5′-TGAGCAACGGGAACAGCTACAA-3′ and 5′-CACCATAAACTTGGCTTCATCCA-3′; kin-32, 5′-CAAAGGCGCTGACCATCATCTA-3′ and 5′-CCGCGTAAATCTGATCAACAGTT-3′; pix-1, 5′-ACAAACTCCAGCGATCTCGATCC-3′ and 5′-CCCATCGTTAGAGTGAATTCTCC-3′; rsu-1, 5′-GAGGTTGAGCATGTCGATCGGA-3′ and 5′-CGGCTTGTTGAATTCCTTTTC-3′; unc-97, 5′-TGGTGTGTGGCGGAATGGATTCC-3′ and 5′-CTTTTGGTCCAGGACTCATCGAT-3′; unc-112, 5′-ATGTTGAACGAGATTGGTCTGAT-3′ and 5′-CCTTGAGATGTCGAATTTCCCAG-3′; pat-3, 5′-ATGCCACCTTCAACATCATTGC-3′ and 5′-CATTACAAGCCAACGCCTGAACA-3′. RNAi constructs were then transformed into E. coli strain HT115, and all RNAi experiments were performed using the feeding method (Timmons et al., 2001). Briefly, we grew RNAi bacterial cultures in selective media for 12–14 h at 37°C, and then for an additional hour following addition of 1 mM IPTG to induce double-strand RNA expression. For codepletion experiments, we mixed the relevant induced bacterial cultures at a 1:1 ratio. Nematode growth medium agar plates containing topically applied 1-M IPTG and 100-mg/ml ampicillin (9 µl each) were then seeded with these RNAi bacterial cultures and left at room temperature overnight for further induction. Synchronized L1 worms were placed on RNAi plates and allowed to feed for 24–96 h at 20°C, depending on the experiment. The L4440 empty vector was used as a negative control for all RNAi experiments. To improve RNAi knockdown efficiency in the pharyngeal tissue, we used worms harboring the lin-35(n745) mutant allele (Shiu and Hunter, 2017), and to enhance sensitivity to RNAi in the gonadal sheath and other tissues, we used the rrf-3(pk1426) genetic background (Simmer et al., 2002). We verified knockdown efficiency for all RNAi experiments, with the exception of the targeted RNAi screen and pat-2; pat-3 double RNAi experiments, by including a control with the relevant mNG/mCherry/mKate2-tagged target protein. We achieved between ∼70 and 100% reduction for all RNAi experiments. For the codepletion of PAT-2 and RAP-3, we verified knockdown efficiency by plate-level assessment of worm paralysis: RNAi initiated at the L1 larval stage against pat-2 alone, or pat-2 and rap-3 in combination, resulted in 100% paralysis of animals by early adulthood.
Confocal differential interference contrast (DIC) and fluorescence images were acquired at 20°C on an AxioImager A1 microscope (Carl Zeiss) controlled by μManager software (Edelstein et al., 2010) and equipped with an electron-multiplying charge-coupled device camera (Hamamatsu Photonics), a 40× Plan-Apochromat (1.4-NA) objective, a spinning disc confocal scan head (CSU-10; Yokogawa Electric Corp.), and 488- and 561-nm laser lines. Worms were mounted on 5% noble agar pads containing 0.01 M sodium azide for imaging. For all experiments except those detailed in Figs. 1 B and S3 A, we captured single-slice images at the middle focal plane of animals where most or all of the gonadal and pharyngeal tissue cross sections were in focus. For Fig. 1 B, we acquired z-stacks at 1-µm intervals spanning the entirety of the pharynx or gonad. For Fig. S3 A, we captured single-slice images at a superficial focal plane, where the body wall muscle was in focus.
Image analysis, processing, and quantification
All quantifications of mean fluorescence intensity were done on raw images in Fiji 2.0 (Schindelin et al., 2012). We drew ∼5–8-pixel-long linescans along the BM to obtain raw values of mean fluorescence intensity. Background intensity values were obtained by averaging two linescans of similar length in regions adjacent to the BM with no visible fluorescence signal. DIC and fluorescence images in all figures were processed in Fiji. The unsharp mask filter was applied to DIC images. 3D isosurface renderings of the pharyngeal and gonadal BMs were constructed using Imaris 7.4 software (Bitplane). Briefly, we acquired z-stacks of pharyngeal and gonadal collagen::mCh in early L1 and young adult worms. Young adult gonads were imaged in sections, and z-stacks of individual sections were stitched together with the Fiji pairwise stitching method (Preibisch et al., 2009). 3D isosurfaces were constructed from these z-stacks by manually tracing the outline of BM collagen::mCh in every z-slice, and surface area measurements were automatically calculated from these isosurfaces by Imaris.
Statistical analysis was performed in GraphPad Prism 7. To blind analysis of fluorescence intensity in all datasets, we used a filename-randomizing macro (courtesy of Martin Höhne, University of Cologne, Cologne, Germany) in ImageJ (National Institutes of Health). Sample sizes were validated a posteriori through assessments of normality by log-transforming all datasets and then using the Shapiro–Wilk test. For comparisons of mean fluorescence intensities between two populations, we used an unpaired two-tailed Student’s t test (with Welch’s correction in cases of unequal variance between samples). To compare mean fluorescence intensities between three or more populations, we performed one-way ANOVA followed by either a post hoc Dunnett’s or Tukey’s multiple comparison test. For comparisons of fluorescence intensity ratios, we used a paired two-tailed Student’s t test (with Welch’s correction in cases of unequal variance between samples). Bar graphs and boxplots were prepared in GraphPad Prism 7. Figure legends indicate sample sizes, statistical tests used, and P values.
Online supplemental material
Fig. S1, related to Fig. 3, shows the quantification of pharyngeal and gonadal BM laminin levels upon lam-2 knockdown. Fig. S2 shows DGN-1::mNG localization at the gonadal sheath–BM interface, dgn-1 knockdown efficiency, and quantification of gonadal BM laminin and collagen levels upon reduction of DGN-1. Fig. S3, related to Fig. 4, shows integrin subunit knockdown efficiency, muscle collagen levels upon integrin knockdown, gonadal BM INA-1::mNG levels upon reduction of PAT-2, and quantification of gonadal collagen levels upon knockdown of various matrix receptors. Fig. S4, related to Fig. 5, shows DGN-1::mNG localization in the head of the worm, integrin subunit knockdown efficiency, and quantification of pharyngeal BM collagen levels upon reduction of matrix receptors. Fig. S5, related to Fig. 7, shows RAP-3::mNG localization in the L1 larva, rap-3 knockdown efficiency, collagen levels upon codepletion of PAT-2 and RAP-3, and PAT-2::mNG and PAT-3::mNG levels upon rap-3 knockdown. Table S1, related to Fig. 7, describes the targeted screen of integrin-associated proteins. Table S2 lists C. elegans strains used in this study.
We thank Brent Hoffman, Kacy Gordon, David Reiner, Arnoud Sonnenberg, Thomas Hannich, Nick Brown, Roy Zent, and members of the Sherwood laboratory for helpful discussions.
Some strains were provided by the Caenorhabditis Genetics Center, which is funded by National Institutes of Health Office of Research Infrastructure Programs (P40 OD010440). E.L. Hastie was supported by American Cancer Society postdoctoral fellowship 129351-PF-16-024-01-CSM, and D.R. Sherwood was supported by the National Institute of General Medical Sciences (Maximizing Investor’s Research Award R35 GM118049), and the National Institute of Child Health and Human Development (R21 HD084290).
The authors declare no competing financial interests.
Author contributions: R. Jayadev and D.R. Sherwood conceived the project. R. Jayadev designed and performed all experiments and analyzed and interpreted the data, with the following contributions from other authors. Q. Chi designed and built molecular biology constructs used in Figs. 2; 4 A; 7, C and E; and 8 and Table S1; D.P. Keeley acquired and analyzed the data on gonadal growth (Fig. 1 B); E.L. Hastie and D.P. Keeley generated the endogenously tagged integrin subunit strains; and L.C. Kelley conceived the integrin chimera experiment (Fig. 6 A). R. Jayadev prepared the figures. R. Jayadev and D.R. Sherwood wrote the manuscript.